Page 13 | Certara

Video

Certara Talks: The role of MIDD in Increasing Pharmaceutical R&D Efficiency

0:05 Hello and welcome to another episode of Certara Talks. 0:07 I'm Doctor Suzanne Minton…

Danielle PillsburyJuly 25, 2025

Conference

AusBiotech International Conference 2025

Danielle PillsburyJuly 25, 2025

Conference

JSSX 2025 in Japan

Danielle PillsburyJuly 25, 2025

On-Demand Webinar

2025 Virtual SEND Explorer® UGM

CertaraJuly 24, 2025

Conference

AAPS 2025 PharmSci 360

CertaraJuly 24, 2025

On-Demand Webinar

Three Approaches to AI Adoption in Regulatory Writing

CoAuthor™ is a GenAI-driven regulatory writing platform, seamlessly integrated with Microsoft Word. By providing efficiency,…

CertaraJuly 23, 2025

Blog

ADNCA Explained: The Next Generation of Non-Compartmental Analysis and the Top Questions Answered

ADNCA is transforming non-compartmental analysis by standardizing workflows, enhancing regulatory confidence, and enabling scalable automation.…

CertaraJuly 23, 2025

Press Coverage

Digital twins and virtual trials: A new era in rare disease drug development

Discover how using digital twins in rare disease drug development is improving precision and accelerating…

CertaraJuly 22, 2025

Press Coverage

The end of animal testing? Transitioning to models is promising — but no silver bullet

The FDA has stated that the pharma industry must transition to using in vitro assays,…

CertaraJuly 21, 2025

Guide

How to Create a Data Validation Plan in Clinical Data Management

Download our guide to creating a data validation plan in clinical data management, the ultimate…

CertaraJuly 21, 2025

Certara Talks: The role of MIDD in Increasing Pharmaceutical R&D Efficiency

AusBiotech International Conference 2025

JSSX 2025 in Japan

2025 Virtual SEND Explorer® UGM

AAPS 2025 PharmSci 360

Three Approaches to AI Adoption in Regulatory Writing

ADNCA Explained: The Next Generation of Non-Compartmental Analysis and the Top Questions Answered

Digital twins and virtual trials: A new era in rare disease drug development

The end of animal testing? Transitioning to models is promising — but no silver bullet

How to Create a Data Validation Plan in Clinical Data Management

Newsletter sign up

Quick links

Solutions

Contact